bromodeoxyuridine has been researched along with vildagliptin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kadowaki, T; Kubota, N; Muraoka, T; Nakamura, A; Orime, K; Sato, K; Shinoda, K; Shirakawa, J; Terauchi, Y; Togashi, Y | 1 |
1 other study(ies) available for bromodeoxyuridine and vildagliptin
Article | Year |
---|---|
Impact of the dipeptidyl peptidase-4 inhibitor vildagliptin on glucose tolerance and β-cell function and mass in insulin receptor substrate-2-knockout mice fed a high-fat diet.
Topics: Adamantane; Animal Feed; Animals; Apoptosis; Bromodeoxyuridine; Dipeptidyl-Peptidase IV Inhibitors; Glucose; Glucose Tolerance Test; Insulin Receptor Substrate Proteins; Insulin-Secreting Cells; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Nitriles; Pyrrolidines; Time Factors; Vildagliptin | 2012 |